期刊文献+

肿瘤相关循环内皮细胞的分类标志物及其功能研究进展 被引量:3

Recent Progress in Classification, Markers and Function of Tumor-related Circulating Endothelial Cells
下载PDF
导出
摘要 经典肿瘤新生血管的形成主要包括血管生成(angiogenesis)和血管发生(vasculogenesis)、均依赖循环内皮细胞(circulating endothelial cells,CECs)的增殖、迁移、黏附而形成管腔。CECs不仅与血管新生和肿瘤生长、播散有关,还可能作为抗血管生成药物的靶点和反映疗效的标志物。循环内皮细胞膜上可表达多种表面分子,在从幼稚到成熟及活化过程要经历不同的阶段,而不同阶段细胞表达的表面分子有所不同。各表面分子在肿瘤血管新生过程中发挥重要作用。监测可靠的分子标志物量化CECs尤其是活化血管内皮细胞(activated circulating vascularendothelial cells,aCECs),来判定肿瘤新生血管和血管靶向治疗的疗效具有重要意义且已成为临床上的迫切需要。本文就肿瘤相关循环内皮细胞的分类、标志物及其功能做一综述。 Two major processes by which tumor blood vessels are developed and remodeled are based on the proliferation, migration, and adhesion of circulating endothelial cells (CECs). CECs therefore contribute to tumor neovasculogenesis and possibly to the progression and metastasis of tumors. CECs are possible targets for antiangiogenic therapy and predictors of treatment efficacy. In this review, we discuss the classification, markers and function of tumor-related CECs.
作者 徐文静 李凯
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2009年第6期353-356,共4页 Chinese Journal of Clinical Oncology
基金 吴阶平基金会临床科研专项基金资助(编号:04101002)
关键词 血管生成 血管发生 循环内皮细胞 内皮祖细胞 Angiogenesis Vasculogenesis Circulating endothelial cells (CECs) Endothelial progenitor cells (EPCs)
  • 相关文献

参考文献22

  • 1Furstenberger G, von Moos R, Lucas R, et al. Circulating endothelial cells and angiogenic serum factors durin.g neoadjuvant chemotherapy of primary breast cancer[J]. Br J Cancer, 2006, 94 (4): 524-531.
  • 2Zhang H, Vakil V, Braunstein M, et al. Circulating endothelial progenitor cells in multiple myeloma:impficafions and significance[J]. Blood, 2005, 105(8): 3286-3294.
  • 3Beaudry P, Force J, Naumov GN, et al. Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells:implications for use as a surrogate marker of antiangiogenic activity[J].Clin Cancer Res, 2005, 11 (9): 3514-3522.
  • 4Del Papa N, Colombo G, Fracchiolla N, et al. Circulating endothelial cells as a marker of ongohag vascular disease in systemic sclerosis[J]. Arthritis Rheum, 2004, 50(4): 1296-1304.
  • 5Untergasser G, Koeck R, Wolf D, et al. CD34+/CD133- circulating endothelial precursor cells (CEP): characterization, senescence and in vivo application[J].Exp Gerontol, 2006, 41(6): 600-608.
  • 6Finney MR, Greco NJ, Haynesworth SE, et al. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia[J]. Biol Blood Marrow Transplant, 2006, 12(5): 585-593.
  • 7Duda DG, Cohen KS, di Tomaso E, et al.Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy[J]. J Clin Oncol, 2006, 24(9): 1449-1453.
  • 8Martin TA, Watkins G, Lane j, et al. Assessing microvessels and angiogenesis in human breast cancer, using VE-cadherin[]]. Histopathology, 2005, 46(4): 422-430.
  • 9Lastres P, Letamendia A, Zhang H, et al. Endoglin modulates cellular responses to TGF-beta1[J].J Cell Biol, 1996, 133(5):1109-1121.
  • 10Charpin C, Dales JP, Garcia S, et al. Tumor neoangiogenesis by GD31 and CD105 expression evaluation in breast carcinoma tissue microarrays[]]. Clin Cancer Res,2004, 10(17): 5815-5819.

二级参考文献36

  • 1徐建明,宋三泰.表皮生长因子受体酪氨酸激酶靶向药物与化疗联合应用的合理设计[J].中华肿瘤杂志,2004,26(6):321-323. 被引量:20
  • 2薛妍,毕锋,刘文超,潘阳林,韩者艺,刘娜,刘长江,申慧琴,张学庸.缺氧状况下Rho GTPases的表达和活性变化及其与肿瘤血管生成关系的研究[J].中华肿瘤杂志,2004,26(9):517-520. 被引量:11
  • 3赵新汉,田洪刚.肿瘤的分子靶向治疗[J].现代肿瘤医学,2005,13(1):133-136. 被引量:3
  • 4Alcalde RE, Terakado N, Otsuki K, et al. Angiogenesis and expression of platelet-derived endothelial cell growth factor in oral squamous cell carcinoma [J]. Oncology, 1997, 54(4):324~ 328
  • 5Lopez-Graniel CM, Tamez de Leon D, Meneses-Garcia A, et al.Tumor angiogenesis as a prognostic factor in oral cavity carcinomas[J]. Exp Clin Cancer Res, 2001, 20(4):463~468
  • 6Risau W. Mechanisms of angiogenesis [J]. Nature, 1997, 386(6626):671-674
  • 7Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation [J]. Nature, 2000, 407(6801) :242 ~248
  • 8Loughna S, Sato TN. Angiopoietin and Tie signaling pathways in vascular development [J]. Matrix Biol, 2001, 20(5~6):319~325
  • 9Lauren J, Gunji Y, Alitalo K. Is angiopoietin-2 necessary for the initiation of tumor angiogenesis [J]? AmJ Pathol, 1998, 153(5):1333~1339
  • 10Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis [J]. Science, 1997, 277(5322):55~60

共引文献35

同被引文献25

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部